These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31305900)

  • 1. CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up.
    Gilles SR; Yohe SL; Linden MA; Dolan M; Hirsch B; Grzywacz B
    Am J Clin Pathol; 2019 Sep; 152(4):471-478. PubMed ID: 31305900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities.
    Takahashi T; Dejbakhsh-Jones S; Strober S
    J Immunol; 2006 Jan; 176(1):211-6. PubMed ID: 16365412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
    Singleterry WL; Henderson H; Cruse JM
    Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
    Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
    Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis.
    Annibali V; Ristori G; Angelini DF; Serafini B; Mechelli R; Cannoni S; Romano S; Paolillo A; Abderrahim H; Diamantini A; Borsellino G; Aloisi F; Battistini L; Salvetti M
    Brain; 2011 Feb; 134(Pt 2):542-54. PubMed ID: 21216829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.
    Shen H; Zhang W; Abraham C; Cho JH
    PLoS One; 2013; 8(3):e57746. PubMed ID: 23469228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8
    Nicol B; Salou M; Vogel I; Garcia A; Dugast E; Morille J; Kilens S; Charpentier E; Donnart A; Nedellec S; Jacq-Foucher M; Le Frère F; Wiertlewski S; Bourreille A; Brouard S; Michel L; David L; Gourraud PA; Degauque N; Nicot AB; Berthelot L; Laplaud DA
    J Autoimmun; 2018 Mar; 88():61-74. PubMed ID: 29054368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique human cord blood CD8
    Reyes JGA; Ni D; Santner-Nanan B; Pinget GV; Kraftova L; Ashhurst TM; Marsh-Wakefield F; Wishart CL; Tan J; Hsu P; King NJC; Macia L; Nanan R
    Immunology; 2024 Sep; 173(1):106-124. PubMed ID: 38798051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-type lectin-like CD161 is not a co-signalling receptor in gluten-reactive CD4 + T cells.
    Wyrożemski Ł; Sollid LM; Qiao SW
    Scand J Immunol; 2021 Jun; 93(6):e13016. PubMed ID: 33368526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.
    Billerbeck E; Kang YH; Walker L; Lockstone H; Grafmueller S; Fleming V; Flint J; Willberg CB; Bengsch B; Seigel B; Ramamurthy N; Zitzmann N; Barnes EJ; Thevanayagam J; Bhagwanani A; Leslie A; Oo YH; Kollnberger S; Bowness P; Drognitz O; Adams DH; Blum HE; Thimme R; Klenerman P
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3006-11. PubMed ID: 20133607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection.
    Wong EB; Akilimali NA; Govender P; Sullivan ZA; Cosgrove C; Pillay M; Lewinsohn DM; Bishai WR; Walker BD; Ndung'u T; Klenerman P; Kasprowicz VO
    PLoS One; 2013; 8(12):e83474. PubMed ID: 24391773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages.
    Fergusson JR; Smith KE; Fleming VM; Rajoriya N; Newell EW; Simmons R; Marchi E; Björkander S; Kang YH; Swadling L; Kurioka A; Sahgal N; Lockstone H; Baban D; Freeman GJ; Sverremark-Ekström E; Davis MM; Davenport MP; Venturi V; Ussher JE; Willberg CB; Klenerman P
    Cell Rep; 2014 Nov; 9(3):1075-88. PubMed ID: 25437561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of frequency and expression level of CD161 in CD8
    Park Y; Lim J; Kim SY; Kwon GC; Koo SH; Kim J
    Microbiol Immunol; 2020 Jul; 64(7):532-539. PubMed ID: 32343447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells.
    Mazzoni A; Santarlasci V; Maggi L; Capone M; Rossi MC; Querci V; De Palma R; Chang HD; Thiel A; Cimaz R; Liotta F; Cosmi L; Maggi E; Radbruch A; Romagnani S; Dong J; Annunziato F
    J Immunol; 2015 Apr; 194(7):3116-26. PubMed ID: 25740946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminating Active Tuberculosis from Latent Tuberculosis Infection by flow cytometric measurement of CD161-expressing T cells.
    Yang Q; Xu Q; Chen Q; Li J; Zhang M; Cai Y; Liu H; Zhou Y; Deng G; Deng Q; Zhou B; Kornfeld H; Chen X
    Sci Rep; 2015 Dec; 5():17918. PubMed ID: 26643453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of T cell prolymphocytic leukemia involving blast transformation.
    Ichikawa K; Noguchi M; Imai H; Sekiguchi Y; Wakabayashi M; Sawada T; Komatsu N
    Int J Hematol; 2011 May; 93(5):667-672. PubMed ID: 21505955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD161(+) T cells as predictive markers for acute graft-versus-host disease.
    Lee SE; Lim JY; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):421-8. PubMed ID: 25543092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Analysis of Peripheral and Colonic CD161
    Lal KG; Phuang-Ngern Y; Suhkumvittaya S; Leeansyah E; Alrubayyi A; Dias J; Waickman A; Kim D; Kroon E; Pinyakorn S; Eller LA; Maciel M; Rerknimitr R; Chomchey N; Phanuphak N; de Souza MSS; Nitayaphan S; Ake JA; Vasan S; Robb ML; Ananworanich J; Sandberg JK; Schuetz A; Eller MA; Paquin-Proulx D
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
    Li L; He J; Zhu L; Yang Y; Jin Y; Jia R; Liu X; Liu Y; Sun X; Li Z
    J Immunol Res; 2015; 2015():307453. PubMed ID: 26436101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.
    Maggi L; Santarlasci V; Capone M; Peired A; Frosali F; Crome SQ; Querci V; Fambrini M; Liotta F; Levings MK; Maggi E; Cosmi L; Romagnani S; Annunziato F
    Eur J Immunol; 2010 Aug; 40(8):2174-81. PubMed ID: 20486123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.